Environmental challenges have never been more critical or more urgent to address than they are today. Growing consumption, industrialization and urbanization threaten not only the sustainability of the environment in which we live, it also impacts the health of people in the communities in which we operate. We must do our part by embracing a circular mindset to have a more positive impact on the environment.

To lead the change, we have taken a bold and broad, company-wide approach to reducing our impact on the environment.

We have adopted a new strategy with the goal to have zero environmental impact.

We will continue to reduce the production of waste sent to landfill and zero loss of water, energy and resources.

We will reduce environmental impact across the supply chain by collaborating with suppliers to encourage circular business practices. We will also increase our use of recycled and carbon-neutral materials and resources.

We will upgrade existing products and design new products based on circular principles as well as work toward a sustainable solution for the reuse and recycling of products.

Our Novo Nordisk headquarters in the U.S. is LEED (Leadership in Energy & Environmental Design) Silver certified, demonstrating our approach to being responsible stewards of our environment. Our commitment to quality and our focus on maintaining high ethical standards goes hand in hand with living up to our responsibilities to shareholders, patients, society and our own employees.

Utilizing recycled and locally sourced materials, the U.S. headquarters is consistent with Novo Nordisk's sustainable business model. The LEED Silver certified campus is fully powered by renewable energy from wind, solar and hydro sources – a feature that is estimated to reduce energy costs by 30 percent. We have also eliminated single use plastics in our U.S. headquarters building, including plastic water bottles, utensils and serving dishes in the cafeteria. 

In 2015, Novo Nordisk joined RE100 and set the goal of transitioning all electricity used in Novo Nordisk production worldwide to renewable sources by 2020. In January 2020 Novo Nordisk U.S. operations connected to the grid in North Carolina with a 105-Megawatt Direct Current (DC) solar energy installation near its facility in Clayton, North Carolina. With this, Novo Nordisk reached its RE100 goal and became the first pharmaceutical company to use only renewable electricity in all of its global production facilities.